In a preliminary report, Caliper Life Sciences, a Hopkinton-based medical technology company, announced better-than-expected fourth quarter revenue of $37 million.
Two product offerings that performed stronger than anticipated helped contribute to the sales increase, which exceeded the company’s benchmark of $33 to $35 million. The company brought in $36 million in the fourth quarter of 2008.
Caliper also benefitted from a licensing agreement with New Jersey based Becton, Dickinson and Co. occurring one quarter earlier than expected.
Year-end earnings are expected to be down by about 3 percent compared to 2008, the company reported. Caliper earned an estimated $130 million for the year, compared to $134 million the year before.
The company also reported cash, equivalents, and securities of about $38 million and $15 million in outstanding short-term borrowing.
